Dietary whey protein lessens several risk factors for metabolic diseases: A review

113Citations
Citations of this article
279Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Obesity and type 2 diabetes mellitus (DM) have grown in prevalence around the world, and recently, related diseases have been considered epidemic. Given the high cost of treatment of obesity/DM-associated diseases, strategies such as dietary manipulation have been widely studied; among them, the whey protein diet has reached popularity because it has been suggested as a strategy for the prevention and treatment of obesity and DM in both humans and animals. Among its main actions, the following activities stand out: reduction of serum glucose in healthy individuals, impaired glucose tolerance in DM and obese patients; reduction in body weight; maintenance of muscle mass; increases in the release of anorectic hormones such as cholecystokinin, leptin, and glucagon like-peptide 1 (GLP-1); and a decrease in the orexigenic hormone ghrelin. Furthermore, studies have shown that whey protein can also lead to reductions in blood pressure, inflammation, and oxidative stress. © 2012 Souza et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Sousa, G. T., Lira, F. S., Rosa, J. C., De Oliveira, E. P., Oyama, L. M., Santos, R. V., & Pimentel, G. D. (2012). Dietary whey protein lessens several risk factors for metabolic diseases: A review. Lipids in Health and Disease. https://doi.org/10.1186/1476-511X-11-67

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free